Prescription drug costs have long been one of the biggest financial stressors for older Americans. Now, a major shift is finally underway, and it could put real money back in seniors’ pockets. Thanks to new rules under the Inflation Reduction Act, Medicare is negotiating drug prices for the first time in history. Early data suggests some medications could see price cuts of up to 50% or more.
For decades, Medicare was not allowed to negotiate drug prices directly with pharmaceutical companies. That changed with the passage of the Inflation Reduction Act, which introduced a formal negotiation program targeting high-cost medications. The first round focuses on drugs with high usage and limited competition. Officials estimate these changes could save billions collectively for both patients and the system.
